Sensei Bio
We follow the immune system’s teachings to discover new treatments that inspire the body to fight cancer.
32 employees · est. 1999 · Rockville, United States
TME Pharma
Developing novel therapies for treatment of the most aggressive cancers by acting on the tumor microenvironment (TME)
12 employees · est. 1998 · Berlin, Germany
TME Pharma is the older company (1999 vs 1998).
Side-by-Side Comparison
| Metric | Sensei Bio | TME Pharma |
|---|---|---|
| Founded | ||
| Founded | 1999 | 1998 older |
| Headquarters | ||
| Headquarters | Rockville, United States | Berlin, Germany |
| Employees | ||
| Employees | 32 | 12 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series B | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $58.50M | $138.73M |
| Funding Rounds | ||
| Funding Rounds | 2 | 13 |
| Services | ||
| Services | Research and Development of Cancer Therapeutics, Clinical Trials for Cancer Treatments, Multi-node Inhibition Therapies | development of novel cancer therapies, conducting and managing clinical trials, scientific research and development, collaborative therapeutic solutions |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Healthcare Providers | oncologists, medical researchers, pharmaceutical companies, healthcare providers, cancer patients |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Cancer Treatment, Drug Discovery, Clinical-stage Biotech, Cancer Immunotherapies, Tumor Microenvironment, Next-generation Therapies, Biologics, ImmunoPhage Platform, Biology, Immunology, Oncology, Therapeutics, Clinical Research | Tumor Microenvironment, Cancer Therapies, Glioblastoma, NOX-A12, Spiegelmer Platform, Immune System Modulation, Chemokine Neutralization, Biopharmaceuticals, Clinical-Stage Company, Immuno-Oncology, Biostable Aptamers, Pharmacologically Relevant Targets, Tumor Defense Mechanism, Oncology Indications, Clinical Collaboration |
| Website | ||
| Website | senseibio.com | tmepharma.com |
About Sensei Bio
Sensei Bio, founded in 1999, is a pioneering player in the Biotechnology and Life Sciences sectors, focused on developing cutting-edge immuno-oncology therapies. Their compelling slogan, "We follow the immune system’s teachings to discover new treatments that inspire the body to fight cancer," succi...
About TME Pharma
TME Pharma is a clinical-stage biotechnology company headquartered in Germany, specializing in developing novel therapies targeting the tumor microenvironment (TME) which is crucial in treating aggressive forms of cancer. With a mission to enhance treatment outcomes, the company’s platform aims at b...
We will tell you when either one moves
BounceWatch watches Sensei Bio and TME Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Sensei Bio and TME Pharma — by email.
Frequently Asked Questions
Compare Sensei Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Sensei Bio on 12 Sep 2024, and TME Pharma on 14 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.